- Home
- ZNTL vs NPCT Comparison
ZNTL vs NPCT Comparison
Compare ZNTL & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- NPCT
- Stock Information
- Founded
- ZNTL 2014
- NPCT 2020
- Country
- ZNTL United States
- NPCT United States
- Employees
- ZNTL N/A
- NPCT N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- NPCT Investment Managers
- Sector
- ZNTL Health Care
- NPCT Finance
- Exchange
- ZNTL Nasdaq
- NPCT Nasdaq
- Market Cap
- ZNTL 105.8M
- NPCT 316.6M
- IPO Year
- ZNTL 2020
- NPCT N/A
- Fundamental
- Price
- ZNTL $1.26
- NPCT $11.23
- Analyst Decision
- ZNTL Buy
- NPCT
- Analyst Count
- ZNTL 7
- NPCT 0
- Target Price
- ZNTL $8.60
- NPCT N/A
- AVG Volume (30 Days)
- ZNTL 1.3M
- NPCT 107.1K
- Earning Date
- ZNTL 08-08-2025
- NPCT 01-01-0001
- Dividend Yield
- ZNTL N/A
- NPCT 9.82%
- EPS Growth
- ZNTL N/A
- NPCT N/A
- EPS
- ZNTL N/A
- NPCT N/A
- Revenue
- ZNTL $26,865,000.00
- NPCT N/A
- Revenue This Year
- ZNTL N/A
- NPCT N/A
- Revenue Next Year
- ZNTL N/A
- NPCT N/A
- P/E Ratio
- ZNTL N/A
- NPCT N/A
- Revenue Growth
- ZNTL N/A
- NPCT N/A
- 52 Week Low
- ZNTL $1.01
- NPCT $8.58
- 52 Week High
- ZNTL $5.44
- NPCT $10.63
- Technical
- Relative Strength Index (RSI)
- ZNTL 45.95
- NPCT 71.14
- Support Level
- ZNTL $1.13
- NPCT $10.55
- Resistance Level
- ZNTL $1.39
- NPCT $11.31
- Average True Range (ATR)
- ZNTL 0.11
- NPCT 0.12
- MACD
- ZNTL -0.02
- NPCT 0.03
- Stochastic Oscillator
- ZNTL 31.71
- NPCT 89.47
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.